Aim To investigate outcomes of newborn hearing screening (NHS) with transient evoked otoacoustic emissions (TEOAE) depending on the time from the birth to hearing screening. Methods A prospective study was performed in the Cantonal Hospital Zenica, Bosnia and Herzegovina. The NHS with TEOAE was done before hospital discharge for all infants. The total of 1217 newborns were tested during a six-month period, from 1 st February to 31 st July 2016. The data of 1167 were available for analysis. Those data were divided in four groups depending on the time passed from the birth to hearing screening: Group A (n = 133 newborns, NHS performed in the first 24 hours after birth); group B (n = 294 newborns, NHS performed between 24-36h after birth); group C (n = 184 newborns, NHS performed between 36-48h after birth) and group D (n= 556 newborns, NHS performed later than 48h after birth). Results Total referral rate was 19.1% (n = 223): for group A 30.1% (n=40), for group B 25.2% (n=74), for group C 19.0% (n=35) and for group D 13.3% (n=74). There was statistically significant difference between groups A and C (p=0.03), between groups A and D (p<0.001) and between groups B and D (p<0.001) in total and in well baby nursery (WBN). Conclusion The total referral rates in NHS were high because of early post birth discharge of newborns. The NHS should be performed in infants older than 36 hours according to the results in this study.
Grandori F, Lutman E. The European consensus development conference on neonatal hearing screening. Am J Audiol. p. 19–20.
2.
Joint Committee on Infant Hearing 1994 Position Statement. Pediatrics. American Academy of Pediatrics; 1995. p. 152–6.
3.
Marn B. Rano otkrivanje oštećenja sluha u djece u hrvatskoj-probir i dijagnostika. Paediatr Croat. 2015. p. 195–201.
4.
Wood A, Sutton J, Davis C. Performance and characteristics of the Newborn Hearing Screening Programme in England: The first seven years. Int J Audiol. 2015. p. 353–8.
5.
Bolat H, Bebitoglu G, Ozbas S, Altunsu T, Kose R. National newborn hearing screening program in Turkey: struggles and implementations between 2004 and. Int J Pediatr Otorhinolaryngol. 2008. p. 1621–3.
6.
Muddasir M, Bilal N, Imran G, Javed C. Screening for hearing impairment in high risk neonates: a hospital based study. J Clin Diagn Res. 2015. p. 18–21.
7.
Parving A. The need for universal neonatal hearing screening-some aspects of epidemiology and identification. Acta Paediatr. 2001. p. 69–72.
8.
Olusanya O, Newton E. Global burden of childhood hearing impairment and disease control priorities for developing countries. Lancet. 2007. p. 1314–7.
9.
Attias J, Al-Masri M, Abukader L, Cohen G, Merlov P, Pratt H, et al. The prevalence of congenital and early-onset hearing loss in Jordanian and Israeli infants. Int J Aud. 2006. p. 528–36.
10.
Yoshinaga-Itano C, Sedey L, Coulter K, Mehl L. Language of early and later identified children with hearing loss. Pediatrics. 1998. p. 1161–71.
11.
Joint Committee on Infant Hearing Year 2007 Position Statement: principles and guidelines for early hearing detection and intervention programs. Pediatrics. 2007. p. 898–921.
12.
Michaelle Van Dyk D, Swanepoel J, Hall. Outcomes with OAE and AABR screening in the first 48h-Implications for newborn hearing screening in developing countries. Int J Pediatr Otorhinolaryngol. 2015. p. 1034–40.
13.
Consistent with the findings of some studies (25,26), in our study it has been shown that referral rate decreased progressively with increasing age. In conclusion, the best recommended time for the NHS in the current conditions in CHZ is after 48 hours from birth. That would be on the third day of an infant’s life or after. The results show that NHS could be done on the second day of the infant’s life but with high risk for referral results. The NHS should not be done in the first 24h of the infant’s life according to the results in this study, which is in accordance with other studies. FUNDING No specific founding was received for this study.
14.
Olusanya O, Emokpae A, Renner K, Wirz L. Costs and performance of early hearing detection programs in Lagos, Nigeria. Trans R Soc Trop Med Hyg. 2009. p. 179–86.
15.
Erenberg A, Lemons J, Sia C, Trunkel D, Ziring P. Newborn and infant hearing loss: detection and intervention. Task Force on Newborn and Infant Hearing. American Academy of Pediatrics; 1998. p. 527–30.
16.
Olusanya O, Bamigboye A. Is discordance in TEOAE and AABR outcomes predictable in newborns. Int J Pediatr Otorhinolaryngol. 2010. p. 1303–9.
17.
Korres G, Balatsouras G, Nikolopoulos T, Korres S, Ferekidis E. Making universal newborn hearing screening a success. Int J Pediatr Otorhinolaryngol. 2006. p. 241–6.
18.
Lupoli M, Garcia L, Anastasio T, Fontana C. Time after birth in relation to failure rate in newborn hearing screening. Int J Pediatr Otorhinolaryngol. 2013. p. 932–5.
19.
White R, Vohr R, Behrens R. Universal newborn hearing screening using transient evoked otoacoustic emissions: results of the Rhode Island Hearing Assessment Project. Semin Hear. 1993. p. 18–29.
20.
Molini E, Calzolaro L, Lapenna R, Ricci G. Universal newborn hearing screening in Umbria region, Italy. Int J Pediatr Otorhinolaryngol. 2016. p. 92–7.
21.
Kemaloğlu K, Gökdoğan Ç, Gündüz B, Önal E, Türkyılmaz C, Atalay Y. Newborn hearing screening outcomes during the first decade of the program in a reference hospital from Turkey. Eur Arch Otorhinolaryngol. 2016. p. 1143–9.
22.
Saki N, Bayat A, Hoseinabadi R, Nikakhlagh S, Karimi M, Dashti R. Universal newborn hearing screening in southwestern Iran. Int J Pediatr Otorhinolaryngol. 2017. p. 89–92.
23.
Canet S, M, Langa S, J. Collar Del Castillo I. Results from ten years newborn hearing screening in a secondary hospital. An Pediatr (Barc). 2016. p. 189–96.
24.
Shang Y, Hao W, Gao Z, Xu C, Ru Y, Ni D. An effective compromise between cost and referral rate: A sequential hearing screening protocol using TEOAEs and AABRs for healthy newborns. Int J Pediatr Otorhinolaryngol. 2016. p. 141–5.
25.
Hrnčić N. Identification of risk factors for hearing impairment in newborns: a hospital based study. Med Glas (Zenica). 2018. p. 29–36.
26.
Benito-Orejas I, Ramırez B, Morais D, Almaraz A, Fernandez-Calvo L. Comparison of two-step transient evoked otoacoustic emissions (TEOAE) and automated auditory brainstem response (AABR) for universal newborn hearing screening programs. Int J Pediatr Otorhinolaryngol. 2008. p. 1193–201.
27.
Vos B, Lagasse R, Leveˆque A. Main outcomes of a newborn hearing screening program in Belgium over six years. Int J Pediatr Otorhinolaryngol. 2014. p. 1496–502.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
